MARKET WRAP: Aspen soars after receiving offers for parts of its business
The local bourse was dragged sharply lower by Naspers and Prosus after Tencent suffered another regulatory crackdown on gaming companies in China
09 September 2021 - 19:04
Aspen Pharmacare shrugged off Thursday’s broad market slump after receiving unsolicited offers for parts of its business, with Naspers and Prosus leading the JSE sharply lower amid another regulatory crackdown on China’s technology sector.
Aspen, SA’s largest pharmaceutical company by market capitalisation, rose the most in four months on Thursday after saying it had received two offers to buy parts of its global active pharmaceutical ingredients (API), which manufacturers the active ingredients used in medications...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.